growth/size/body
• the heart to body weight ratio is increased by 20% compared to non-transgenic controls
|
• approximate 2.5-fold increase in heart weight, suggesting eccentric cardiac hypertrophy in the late stages of cardiomyopathy
|
• myocytes located in the right ventricle have a 62% higher cross-section than found in non-transgenic controls
|
mortality/aging
• average age of death is 8.6 +/- 0.7 months
• males survive longer than females, dying on average at 12.4 months compared to 7 months for females
|
cardiovascular system
N |
• systolic and diastolic blood pressure is normal in these mice
|
• heart muscle contains elevated levels of diacylglycerol resulting from enhanced signaling by the alpha 1 adrenergic receptor through the Gq-phospholipase C-protein kinase C signaling pathway
|
• left ventricular walls exhibit myofibrillar disarray
|
• distortion of both ventricles
|
• the heart to body weight ratio is increased by 20% compared to non-transgenic controls
|
• approximate 2.5-fold increase in heart weight, suggesting eccentric cardiac hypertrophy in the late stages of cardiomyopathy
|
• myocytes located in the right ventricle have a 62% higher cross-section than found in non-transgenic controls
|
• left ventricular end-systolic area and left ventricular end-diastolic area are higher at 6 and 9 months of age but not at 3 months, indicating progressive left ventricle enlargement with age
|
• all 4 cardiac chambers are enlarged
• however, posterior and septum wall thickness are largely unchanged
|
• mice exhibit late-onset dilated cardiomyopathy
|
• fractional area change is decreased between 3 and 9 months of age by about 20%, indicating loss in left ventricular systolic function
|
• left ventricular end-systolic area and left ventricular end-diastolic area are higher at 6 and 9 months of age but not at 3 months, indicating progressive left ventricle enlargement with age
• left ventricular end-systolic area is increased over 80% from 3 to 9 months of age
• fractional area change is decreased between 3 and 9 months of age by about 20%
|
• mice present with signs of heart failure, including fatigue and dyspnea, followed by generalized edema and death
|
homeostasis/metabolism
• frequent presence of right atrial thrombus
|
• seen before mice die
|
muscle
• heart muscle contains elevated levels of diacylglycerol resulting from enhanced signaling by the alpha 1 adrenergic receptor through the Gq-phospholipase C-protein kinase C signaling pathway
|
• left ventricular walls exhibit myofibrillar disarray
|
• myocytes located in the right ventricle have a 62% higher cross-section than found in non-transgenic controls
|
• mice exhibit late-onset dilated cardiomyopathy
|
• fractional area change is decreased between 3 and 9 months of age by about 20%, indicating loss in left ventricular systolic function
|
respiratory system
• seen before mice die
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:134704 |